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LIST OF NON-STANDARD ABBREVIATIONS 
 
AGE: Advanced glycation end products 
ApoD: Apolipoprotein D 
BSA: Bovine serum albumin 
CNS: Central nervous system 
da: daughterless 
DMF: N,N-dimethylformamide 
ECL: Enhanced chemiluminescence 
EDTA: Ethylenediaminetetraacetic acid 
FOXO: Forkhead box O1 protein 
GLaz: Glial Lazarillo 
GPI: Glycosylphosphatidylinositol 
hApoD: human Apolipoprotein D 
HRP: Horseradish peroxidase 
IgG: Immunoglobulin G 
IIS: Insulin/IGF signaling (IGF: insulin-like growth factor) 
JNK: Jun-N-terminal Kinase 
Kd : Dissociation constant 
Lcn2: lipocalin 2 
L-PGDS: lipocalin type - Prostaglandin D synthase 
NGAL: Neutrophil gelatinase-associated lipocalin 
NLaz: Neural Lazarillo 
NLaz-KO: Neural Lazarillo knock-out mutant 
PNGase-F: peptide-N-glycosidase F 
PQ: Paraquat 
RA: retinoic acid 
RBP: Retinol Binding Protein 
RpL32: Ribosomal protein L32 
SDS-PAGE: sodium docecyl sulphate - polyacrylamide gel electrophoresis 
TI: Trypsin inhibitor 
TOR: Target of rapamycin protein 
UAS: Upstream activated sequence 
WT: wild type 
  
 3
ABSTRACT 
 
Lipocalins are small extracellular proteins mostly described as lipid carriers. The 
Drosophila lipocalin NLaz (Neural Lazarillo) modulates the IIS pathway and 
regulates longevity, stress resistance, and behavior. Here we test whether a native 
hydrophobic pocket structure is required for NLaz to perform its functions. We use a 
point mutation altering the binding pocket (NLazL130R) and control mutations outside 
NLaz binding pocket. Tryptophan fluorescence titration reveals that NLazL130R loses 
its ability to bind ergosterol and the pheromone 7(z)-tricosene, but retains retinoic 
acid binding. Using site-directed transgenesis in Drosophila we test the functionality 
of the ligand binding-altered lipocalin at the organism level. NLaz-dependent lifespan 
reduction, oxidative stress and starvation sensitivity, aging markers accumulation, and 
deficient courtship are rescued by overexpression of NLazWT, but not of NLazL130R. 
Transcriptional responses to aging and oxidative stress show a large set of age-
responsive genes dependent on the integrity of NLaz binding pocket. Inhibition of IIS 
activity and modulation of oxidative stress and infection-responsive genes are binding 
pocket-dependent processes. Control of energy metabolites upon starvation appears to 
be, however, insensitive to the modification of the NLaz binding pocket. 
 
Keywords:  
Aging 
Oxidative stress 
Lipid-binding proteins 
Pheromonal signalling 
Metabolism regulation 
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INTRODUCTION 
 
Lipocalins are a large family of small extracellular proteins characterized by their 
well conserved β-barrel structure embracing an internal cavity able to bind small 
ligands, most of them hydrophobic or amphipathic (1). For some lipocalins we have a 
good approximation to the role played by their native ligand. For instance, Retinol 
Binding Protein (RBP) transports vitamin A within the retina (2); Siderocalin (Lcn2 
or NGAL) sequesters iron-binding molecules and provides a bacteriostatic mechanism 
against infections (3); and Crustacyanins carry the pigment giving color to the 
carapace of crustaceans (4). However the panoply of different physiological functions 
in which lipocalins are involved, many of them tested by altering their expression 
levels in genetically-modified organisms (5-8), keeps increasing, and in the vast 
majority of cases a ligand transport function is assumed but not tested. 
 
A set of lipocalins, including the most ancient ones within the metazoan lineage (9-
11), has been functionally linked to the response of organisms to different forms of 
stress and to the modulation of metabolism, key parameters regulating senescence and 
longevity (reviewed by 12). Among these are the Lazarillo-related lipocalins, a group 
including the Drosophila lipocalins Neural Lazarillo (NLaz) and Glial Lazarillo 
(GLaz) (13) and the vertebrate Apolipoprotein D (ApoD). The expression of these 
lipocalins, both within and outside the nervous system, is boosted by oxidative or 
metabolic stress and they provide an endogenous mechanism of protection 
particularly important in situations of aging and neurodegeneration (5, 14-20). 
 
NLaz is induced under the control of the stress responsive JNK pathway, and is able 
to negatively regulate the IIS pathway (16, 21). NLaz expression increases stress 
resistance and longevity, but also serves other apparently unrelated functions by 
regulating fecundity, food-intake and locomotor and courtship behaviors (18, 22). The 
molecular mechanism by which NLaz is able to perform these varied functions has 
not been elucidated yet, although general proposals of lipid-transport or interaction 
with cellular lipid membrane surfaces have been laid out (23, 24). Whether all NLaz 
functions are carried out using a common biochemical mechanism, or this lipocalin 
can exert different functions depending on the ligand available for binding in different 
physiological situations, is still unknown. 
 
Studies testing ligand binding abilities of lipocalins in vitro are abundant (25-27), 
including ApoD and Lazarillo-related lipocalins (23, 28-32). In addition, many 
lipocalins have been extensively studied at the molecular level, revealing particular 
residues and regions of the protein scaffold that are important for their ligand binding 
properties (25, 27, 33-36). The biochemical and biophysical properties of lipocalin-
ligand interactions have been reported for some family members, either by solving 
their crystal structure with the ligand bound to the pocket (31, 37) or by site-directed 
mutagenesis of residues contributing to the pocket interactive surfaces (26, 27, 35-
41). Amino acid substitutions that naturally occur in the binding pocket of RBP result 
in vitamin A deficiency causing night blindness (42). Also, thanks to their very robust 
fold, the lipocalins have been used as starting point for protein engineering. Using 
site-directed random mutagenesis followed by selection techniques, an increasing set 
of so-called “Anticalins” has been generated with various specific target binding 
activities, many of them with potential therapeutic benefits (for a review see 43).  
 
 5
In spite of the many known lipocalin mutant forms that result in deficient ligand 
binding in vitro, studies analyzing their effects outside the test tube are rare. Mutant 
forms of Prostaglandin D synthase (L-PGDS) have recently been tested for their 
ability to promote cell survival in H2O2 treated neuronal cultures (44). A mechanism 
involving the titration of a free thiol in the protein without alterations of ligand 
binding capacity has been found. Modifications of the binding pocket of the lipocalin 
C8 have been tested for hemolytic activity (35). Also, Correnti et al. (39) have found 
that Siderocalin binding pocket mutants that cannot bind siderophores in vitro lose 
their bacteriostatic activity when added to bacterial cultures. 
 
The purpose of this study is to test whether the functions of the lipocalin NLaz are 
dependent on ligand binding. We designed different mutant forms of NLaz and tested 
them at three levels of analysis. We assayed their ligand binding capacity in vitro, 
their cell survival promoting activity in a cell culture system, and their effect on 
longevity, stress resistance, behavior and downstream transcriptional responses in 
vivo. By using site-directed transgenesis in Drosophila, we were able to compare the 
physiological effects of wild type and mutant NLaz expression without the 
confounding effect of transgene insertion site in the genome. This is, to our 
knowledge, the first in vivo test of the physiological outcome derived from a ligand 
binding-altered lipocalin at the organism level. 
 
MATERIALS AND METHODS 
 
Homology modeling of NLaz 3D structure. 
The NLaz model was obtained from the Swiss Model Repository platform (45, 46), 
built using the atomic coordinates of hApoD [PDB entry: 2HZQ] as the best template 
(31). An estimation of the model quality was assessed by the QMEAN Server 
(http://swissmodel.expasy.org/qmean/cgi/index.cgi) (47). 
 
Cloning, S2 cell lines generation, and stress assays.  
NLaz cDNA, translating into residues 1-224 (CG33126, Uniprot reference 
Q9NAZ4, FlyBase entry FBgn0053126), was subcloned with a C-terminal 6xHis tail 
into the pRmHa3 vector as previously described (23). NLazL130R-pRmHa3 was 
generated by direct mutagenesis of NLazWT-pRmHa3 following the Quick Change 
Site Direct Mutagenesis method (QIAgen). Table 1 lists the oligonucleotides used for 
mutagenesis, cloning, and sequencing. Transfected cells were selected with 25 μg/ml 
blasticidin-S for 3 weeks (Invitrogen). 
S2 cells seeded at a density of 2x106/ml were treated with H2O2 as an oxidant agent 
in the presence of pure NLazWT, NLazL130R (see below) or a control protein (trypsin 
inhibitor from soybean, Sigma) as previously described (22). Viability was scored in 
quadruplicate wells with at least two measurements in each culture well. 
 
Purification of NLazWT and NLazL130R proteins. 
Protein expression was induced in the stably transfected S2 cell lines and purified 
by metal-affinity chromatography followed by two rounds of size-exclusion 
chromatography (Supplementary Figure 1a), as previously described (23). The 
purified proteins were deglycosylated by treatment with peptide-N-glycosidase F 
(PNGase-F) from Flavobacterium meningosepticum (New England Biolabs) after 
denaturation following the protocol supplied by the manufacturer. The purified 
proteins were analyzed by 12% SDS-PAGE (Supplementary Figure 1b). 
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Ligand binding assays by tryptophan fluorescence titration 
Fluorescence measurement were conducted as described (23) with either NLazWT 
and NLazL130R diluted at 1 μM in 10 mM phosphate buffer, 150 mM NaCl, 1 mM 
EDTA at pH 7.0. The ligands tested were Retinoic Acid (Sigma), Ergosterol (Sigma) 
and 7(z)-Tricosene (Cayman), and were dissolved in N,N-dimethylformamide (DMF) 
(Sigma). An apparent Kd was estimated with the assumption of a single binding site. 
 
Generation of transgenic flies by site-specific transgenesis. 
NLaz loss-of-function mutant (NLaz-KO) was generated in a w1118 background 
(48) and crossed with a w1118-CS wild type (WT) line to generate the NW5 line used 
in this study (16). 
The full wild type and L130R NLaz cDNAs were subcloned into the pUASt-attB 
vector (49) (Gen Bank entry EF362409 and FlyBase entry FBmc0003002). A C-
terminal truncated version of NLaz was generated by amplifying a cDNA fragment 
translating into residues 1-176 of NLaz. NLazN165S was identified by sequencing as a 
polymorphism in some of our wild type fly stocks. These NLaz versions were also 
subcloned into the pUASt-attB vector. Constructs were sequenced to confirm 
orientation and the absence of undesirable mutations. See Table 1 for oligonucleotides 
used for mutagenesis and cloning. 
PhiC31 system-mediated (49) transformation of Drosophila strain “y1 M{vas-
int.Dm}ZH-2A w*; M{3xP3-RFP.attP}ZH-86Fb” (BL4749) was used to generate fly 
lines with all the transgenes inserted in the same chromosomal position (86Fb). NLaz 
transcription levels in the transgenic flies expressing NLazWT or NLazL130R was 
compared using primers able to amplify both forms, and a mutant-specific primer that 
does not amplify the WT allele (Table 1). The amounts of mRNA of the NLazL130R 
mutant version are similar to those of the WT transcript in the transgenic flies 
(Supplementary Figure 1d). The expression levels of NLaz transcripts in flies 
expressing NLazN165S or NLazΔ177-192 are similar to those of WT over-expresser 
(Supplementary Figure 1d). 
 
Fly handling, lifespan, stress sensitivity and behavioral assays. 
Flies were grown in standard laboratory conditions as described (19). Fly survival 
was assayed in standard media for lifespan determination (n=76-147 male flies/ 
genotype), in vials with filter papers soaked in 10% sucrose-20 mM paraquat (PQ) 
(Sigma), for oxidative stress sensitivity  measurement, or in empty vials for 
starvation-desiccation sensitivity measurements (n=67-153 male 
flies/genotype/condition) as previously described (18). Tubes containing the flies 
were genotype-blinded, and the counting of dead flies in the numbered tubes was 
randomly performed by two trained observers (M.R. and a lab technician). All tests 
were carried out at 25ºC. 
To drive the expression of the NLaz transgenes, the driver da:Gal4 (ubiquitous 
expression) line was crossed with pUASt-NLaz fly lines or w1118 flies (to generate 
driver-only control flies).  
The absence of infection by Wolbachia pipiens in our fly strains (Supplementary 
Figure 1c was tested as described (18). 
Courtship and mating tests were performed by a trained observer (M.R.) as 
described (18). The courtship index, representing the proportion of time a male 
spends actively courting the female for the first 10 min, was scored in 25-30 
couples/genotype. 
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Wild-type flies (expressing the driver alone, w1118 ; da:Gal4/+) were used as 
control in over-expression experiments, whereas NLaz-KO flies (w1118 ; NLaz 
NW5/NLaz NW5 ; da:Gal4/+) are the control in rescue experiments. All UAS:NLaz 
transgenes are located in the same locus of the genome (86Fb in chromosome 3). 
 
Metabolic Measurements and AGE assay. 
Flies (4-5 day-old) were studied in basal situation and after 8 hours of starvation. 
Two independent groups of 15 flies per genotype and condition were analyzed. A set 
of kits were used for triglycerides (BioSystems, Spain), glucose (Sigma, USA) and 
glycogen (Sigma, USA) measurements, following the manufacturers’ instructions. 
Absorbance was measured by a Versamax microplate reader (Molecular Devices). 
Fluorescent AGEs (advanced glycation end products) were measured as described 
(22). 
 
Quantitative RT-PCR gene expression array. 
RNA from pools of 25 homogenized flies per genotype and condition was 
extracted and reverse transcribed as previously described (18). We used SYBR Green 
and designed a custom qRT-PCR array (SABiosciences) with 4 replicas per sample to 
study gene expression changes generated by the expression of NLazWT or its mutant 
versions. RNA transcription profiles were determined by the method of direct 
comparison of Ct values and relative quantities calculated by the ΔΔCt method (50). 
The list of genes explored and their relationship to the physiological output that 
motivated each gene selection is shown in the Supplementary Data File 1. A fold 
regulation ≥ 2 and p < 0.05 for at least one genotype was established for the gene to 
be considered as a PQ or aging-responsive gene (Supplementary data file 2).  
 
Statistical analyses. 
Statistical analyses were performed with SigmaPlot (v 11.0) software. A p< 0.05 
was defined as a threshold for significant changes. ANOVA was used when assaying 
for multiple comparisons. The particular tests used for post-hoc analyses depended on 
homoscedasticity, and are stated in figure legends. Multiple survival curves were 
compared with a log-rank test followed by Holm-Sidak multiple comparison post-hoc 
test. 
 
RESULTS 
 
In order to design mutations that could result in altered ligand binding properties we 
modeled the NLaz tertiary structure in the Swiss Model platform (Figure 1a-b). The 
average RMSD of the NLaz model is 3.71Å, and that for the β-sheet and α-helices is 
0.74 Å. The QMEAN quality estimate is 0.707, passing the threshold for a reliable 
model. Based on the well known ligand-protein interactions of the closely related 
ApoD (31) we designed a binding pocket mutant (NLazL130R; Figure 1b) predicted to 
hinder ligand binding by introducing a charged residue with a large side chain facing 
the pocket. Different mutations were then selected as controls. An NLaz allele with a 
serine in position 165 was found in our wild-type fly stocks, while an asparagine in 
that position appears in the NLaz sequence of the genome Drosophila database. In this 
work, the N165 version was selected as the reference wild-type protein, matching the 
current entries in genomic databases. The NLazN165S version might represent a 
polymorphism present in laboratory flies. Since N165 lies outside the binding pocket 
(Figure 1a and Supplementary Figure 2a), it has the potential to show the 
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physiological outcomes of expressing an NLaz point mutant unrelated to ligand 
binding. We also explored the effect of deleting a C-terminal extension (residues 177-
192, Figure 1a and Supplementary Figure 2d,e), which is unique to NLaz within the 
lipocalin family (51), as a different control for the NLazL130R binding pocket mutant. 
This C-terminal tail is similar in size to the GPI-anchoring signal peptide present in 
the lipocalin Lazarillo of grasshoppers and other insects (22, 52), but shows a quite 
different amino acid composition. 
 
Monitoring NLaz-ligand interactions in vitro by intrinsic fluorescence analysis 
 
The proteins of interest were expressed using an inducible expression system in 
Drosophila S2 cells. The proteins were purified from the culture medium by affinity 
chromatography against a C-terminal His-tag followed by two rounds of size 
exclusion chromatography to reach a purity > 99% (Supplementary Figure 1a). The 
proteins produced by S2 cells were successfully secreted into the culture medium, are 
glycosylated and show signs of intramolecular disulfide bonds, as expected for a 
correctly folded native NLaz protein (Supplementary Figure 1b). We centered our 
biochemical analysis on the ligand binding properties of NLazWT and NLazL130R. 
We used tryptophan fluorescence titration to assay the interaction of NLaz with 
different ligands (Figure 1c-h). One of the two tryptophan residues in NLaz, W128, is 
predicted to be located within the binding pocket. Its modification by interaction with 
ligands in the pocket could either quench or enhance its fluorescence emission. All-
trans-retinoic acid (RA) produced quenching of the emitted fluorescence (Figures 
1c,f) in both, NLazWT and NLazL130R. RA binding, which is present in most lipocalins 
tested so far (29, 53-55), substantiates the correct folding of the S2 expressed 
proteins. We then tested ergosterol, the functional equivalent to mammalian 
cholesterol in insects, and proved that it produces an enhanced fluorescence over the 
carrier baseline in NLazWT (Figure 1d), but not in NLazL130R (Figure 1g). The same 
pattern was observed with the pheromone 7(z)-tricosene (56) (Figures 1e,h) 
demonstrating that the alteration of the pocket introduced by the L130R mutation was 
compromising the binding to ligands of different sizes, molecular properties and 
presumed biological functions. Similar apparent Kd for the ligand–protein interaction 
have been obtained for RA-lipocalins by us and others (28, 29). Ergosterol and 
7(z)tricosene have been tested for the wild type version of NLaz  showing a Kd of 2.7 
μM and 4.5 μM respectively (23). However, no binding was detected in the 
micromolar range for NLazL130R. 
 
NLazWT has stronger cell survival promoting activity than NLazL130R under 
oxidative stress in a cell culture-based assay. 
 
In order to test the biological activity of the wild type and ligand binding-altered 
NLaz, we treated non-transfected S2 cell cultures with H2O2 and measured cell 
viability by trypan blue exclusion analysis (Figure  2a). Neither version of NLaz 
protein nor an unrelated control protein (Trypsin Inhibitor) had effects on the viability 
of untreated cells. Upon a pro-oxidant treatment the viability of control cells was 
reduced to 45%. No rescue was observed when the culture was supplemented with the 
control protein, but a significant increase in viability was obtained with both NLazWT 
and NLazL130R. The increase in viability produced by NLazWT was nevertheless 
significantly higher than that obtained with the pocket mutant NLazL130R. 
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Monitoring the survival promoting activity of NLazWTand mutant forms in vivo. 
 
The wild type and mutant versions of NLaz were placed downstream of an UAS 
(upstream activated sequence)-containing promoter to control their expression by the 
Gal4/UAS system in Drosophila. Using PhiC31-mediated transformation all the 
transgenes were integrated into the fly genome in position 86Fb of chromosome 3, an 
otherwise neutral site with no phenotypic effects known due to insertion mutations 
(See Methods section). This strategy aims at ameliorating differences of genetic 
background and positional effect in expression levels (see Supplementary Figure 1d) 
and tissue distribution, thus allowing a proper comparison of the effects of different 
NLaz versions on the fly physiological parameters. In this work we study the 
ubiquitous expression of the transgenes using the daughterless:Gal4 (da:Gal4) driver. 
The combination of this driver with the single-site responding transgenes allows for 
comparisons across genotypes throughout the life of the fly. 
 
Drosophila resistance to oxidative stress throughout aging is differentially 
modulated by NLaz mutant versions. 
 
We previously demonstrated that the expressions of NLaz and its mammalian 
homologue ApoD are naturally induced, via JNK signaling activation, upon exposure 
to the oxidative stress generator paraquat (PQ) (14, 16). The expression of 
NLaz/ApoD is required to promote survival of both flies and mice under oxidative 
stress conditions (5, 16, 57). 
When flies are exposed to PQ and NLazWT is overexpressed with a ubiquitous 
pattern (da:Gal4 driver), young 3 day-old flies increase moderately their survival 
(Figure 2b), but aged flies (30 day-old) experience a 13.6 and 40.2% increase in 
median and maximal survival respectively (Figure 2c and Table 2). In contrast, over-
expression of the pocket mutant NLazL130R does not increase, but causes a reduction 
in the survival of flies (Figures 2b-c and Table 2) with a 13.5 and 8.9% decrease in 
median and maximal survival of WT aged flies respectively. When the expression of 
NLazWT or NLazL130R is performed in the NLaz null background (flies homozygous 
for the allele NLazNW5) the ligand binding-altered version cannot rescue the 
sensitivity to PQ to the level attained by expressing the wild type NLaz version 
(Figure 2d). Taken together, these results are in agreement with a need of a native 
ligand binding activity for NLaz to exert its protective effect upon oxidative stress. 
NLazN165S, bearing a mutated residue located outside the binding pocket 
(Supplementary Figure 2a), results in extended survival upon PQ treatment in young 
flies in wild type background, as well as in flies lacking native NLaz (Supplementary 
Figures 2b-c, and Table 2). Whether this NLaz allele represents a stress resistance 
promoting polymorphism existing in naturally occurring fly populations deserves 
further studies. 
The mutant NLazΔ177-192 is also predicted not to alter the ligand binding properties 
of NLaz. It results in a survival curve similar to NLazWT in young flies exposed to PQ 
(Supplementary Figure 2d). In the NLaz null mutant background this truncated 
version of NLaz produces a partial rescue of median survival, but a complete rescue 
of maximal survival (Supplementary Figure 2e and Table 2). These data again 
reinforce the idea that the altered ligand binding pocket generated by the L130R 
mutation, unlike other NLaz protein modifications, decreases significantly the NLaz 
protective effects upon PQ exposure. 
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A native binding pocket is required to rescue the Drosophila longevity reduction 
phenotype of the NLaz null mutation. 
 
Since resistance to oxidative stress is often correlated with extended longevity, we 
tested the ability of NLazL130R to rescue the decrease in lifespan caused by the absence 
of NLaz (16). 
Expressing the ligand binding-altered NLazL130R in the NLaz null background 
results in a lifespan shorter than that of the null mutant (Figure 2e, Table 2). This 
result is compatible with a requirement for a native ligand binding activity in NLaz in 
order to obtain a wild type-like longevity pattern. However, it also suggests a 
potential dominant-negative effect of the NLazL130R protein. Interactions of NLazL130R 
with NLaz functional partners might be more deleterious than the absence of NLaz. 
 
Aging-related markers accumulate early in NLaz null mutant, and their rescue is 
dependent on NLaz pocket integrity. 
 
We have previously shown that the accumulation of oxidized forms of sugars (AGEs), 
which are reliable biomarkers of normal aging-related damage, is accelerated in the 
NLaz null mutants (22). The increase in fluorescent AGEs caused by the lack of NLaz 
is fully rescued by the ubiquitous expression of NLazWT, but not by NLazL130R (Figure 
3a), indicating that the beneficial action of NLaz in the delay of age-related damage is 
dependent on its ligand binding ability. 
 
Fly reproductive behavior also depends on NLaz binding pocket structure. 
 
Since parameters controlling reproduction have also an impact on the rate of aging 
and longevity, we explored male courtship performance, which is significantly 
reduced in null NLaz flies ((18) and Figure 3b). NLazWT rescues this phenotype, 
while the courtship index of males expressing NLazL130R is more similar to the null 
mutant flies than to the wild type control (Figure 3b). This result, together with the 
inability of NLazL130R to bind a key male pheromone (Figure 1h), suggests that NLaz 
binding to specific ligands contributes to the mechanisms controlling courtship 
behavior.  
 
Drosophila resistance to metabolic stress is affected by NLaz ligand binding 
pocket structure. 
 
Resistance to metabolic stress is also correlated with an extended longevity, and we 
have described how NLaz expression can be triggered upon starvation-desiccation 
conditions and modulates metabolism by acting on the IIS pathway (16). 
Consequently, a loss of NLaz decreases resistance of flies to the lack of nutrients and 
water. As expected, the over-expression of NLazWT significantly increases the 
resistance of NLaz null flies to starvation-desiccation stress (Figure 2f, Table 2). 
However, the NLazL130R point mutant exhibits only a partial rescue of the null mutant 
phenotype (Figure 2f, Table 2). 
 
Measurements of metabolic state: NLaz binding pocket integrity does not affect 
the metabolic response to starvation. 
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Energy management and metabolism is tightly linked to longevity regulation and the 
rate of aging (reviewed by 12). We have previously shown that triglyceride, glucose 
and glycogen levels are decreased during starvation levels in NLaz null mutants than 
in NLaz WT (16). NLaz is induced in response to stress (16) or to a high sugar diet 
(21), and exerts a negative regulation on the IIS pathway.  
Here we explore the effects of eight hours of starvation-desiccation stress on 
triglycerides, glucose and glycogen levels of flies expressing NLazWT and NLazL130R 
in the null mutant background. The depletion of triglycerides, glucose and glycogen is 
significantly larger in the absence of NLaz (Figure 4a-c). This phenotype is either 
partially or totally rescued by both NLazWT and NLazL130R. Therefore, energy storage 
management in response to starvation appears to be unaffected by the altered binding 
pocket of NLazL130R. 
 
Transcriptional responses to oxidative stress or aging are modulated by NLaz 
and are differentially rescued by NLazWT and NLazL130R transgenes. 
 
The expression of a set of 40 genes was explored in the same four fly genotypes as 
above (Figure 5) using a custom qRT-PCR array (see Methods). Genes were selected 
to monitor the state of pathways regulating metabolism, aging and stress biomarkers, 
lipid and carbohydrate metabolism, and pheromonal and neuropeptide signaling. The 
other two known Drosophila lipocalin genes (GLaz and Karl) were also included 
together with genes related to the innate immune response, given the infection-
protective effect known for Karl (16). In addition to technical controls, four potential 
housekeeping genes were included. Among those, in agreement with the criteria of 
Ponton et al. (58), we found that RpL32 is the one with least variation among 
genotypes and conditions, and was used as a reference for the analysis. Each genotype 
was explored under basal conditions (3 day-old flies), upon PQ exposure (17 h 
treatment, 3 day-old flies), and with aging (30 day-old flies). 
In untreated young flies, the differences between genotypes are small, and only 
three genes (Dpt, Karl and llp4) fulfill our criteria of altered expression (see Methods) 
in the NLaz null mutant with respect to heterozygous control flies (Table S2 in 
Supplementary data file 1). Among these, the expression pattern of the lipocalin Karl 
is of particular interest: its expression decreases in the NLaz null mutant and is 
recovered by both NLazWT and NLazL130R ubiquitous expression. 
PQ exposure provoked a transcriptional response in 23 of the 40 genes studied 
while aging modified the expression of 24 genes (Supplementary data file 2). In 
Figure 5 we show the subsets of responding genes where NLazWT or NLazL130R revert 
the transcriptional change observed in the NLaz null mutant. NLaz ubiquitous 
expression is able to rescue the effects of PQ in 12 genes (Figure 5a), representing 
over half the sample of responding genes (Figure 5b). Interestingly, NLaz over-
expression rescues the expression of 17 aging-dependent genes (Figure 5c), 
representing three quarters of the sample (Figure 5b). Furthermore, a differential 
rescue by the NLazWT transgene is particularly enriched in the aging-dependent gene 
sample with approximately half the rescuing effects being dependent on a native 
NLaz ligand binding pocket (binding pocket dependent vs. independent fractions in 
Figure 5b). 
In the transcriptional response to PQ we found three genes whose expression is 
differentially rescued by the NLazWT transgene (boxed in Figure 5a). They are 
functionally related to lifespan modulation (Lsp2, (59)), detoxification, oxidative and 
heat stress response (GstE1, (60)), and regulation of neurogenesis by metabolism 
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(Ilp4, (61)). In the response to aging more genes show binding pocket-dependent 
rescue by NLaz (boxed in Figure 5c). They include genes directly involved in the IIS 
pathway activity (InR, (12)) and oxidative stress responsive genes that are in turn 
regulated by the IIS pathway (Gadd45, (62)), genes downstream of the stress-
responsive JNK pathway (puc, Karl and Hsp68, (16, 63)), genes related to the 
immune response (the antibacterial peptide Drs and Karl, (16, 64)), aging-modulated 
neuropeptides and synaptic proteins (Nplp3 and synaptogyrin (59)), as well as 
neuropeptides controlling food-intake (sNPF, also downstream of IIS pathway (65-
67)). 
Among the tested genes, NLaz binding pocket-dependent transcriptional changes 
were not observed for genes that we had selected for their direct relationship to 
pheromone synthesis, lipid homeostasis or lipid metabolism. 
 
 
DISCUSSION 
 
In this study we have tested in vivo the requirement of a native ligand binding activity 
for the lipocalin NLaz to fulfill its physiological functions. 
The mutation L130R renders NLaz unable to bind different types of ligands 
(ergosterol and 7(z)-tricosene). This modification hinders the survival promoting 
activity of NLaz, both in a cell-based culture system and in vivo, where it is unable to 
rescue the effects of the NLaz null mutation upon oxidative or metabolic stress. 
NLazL130R does not rescue the accumulation of an age-dependent marker, and it 
appears to show a dominant-negative effect in lifespan modulation. Therefore, the 
residue L130 appears to be a key element in the ligand binding abilities of NLaz in 
vivo, as it has been shown in vitro for its human homologue ApoD. The crystal 
structure of hApoD bound to progesterone, a ligand of the same structural class as 
ergosterol, shows the residue L129 (equivalent to L130 in NLaz) in direct contact 
with the ligand (31). When modeling the binding of a very different lipid, arachidonic 
acid, the same residue shows up as an interacting partner in hApoD (31). L130 lies in 
close proximity to a tryptophan residue conserved in the entire lipocalin family 
(W127 in hApoD, W128 in NLaz), which is also known to be involved in the protein-
ligand interaction and is probably responsible for most of the intrinsic fluorescence 
changes observed upon ligand binding in our assays. However, the L130R 
substitution is predicted to alter a particular sub-site of the binding pocket. Therefore, 
as confirmed by our results, the binding of chemically distinct ligands can be 
differentially affected. 
Our analysis also shows that the ligand binding-altered version of NLaz 
(NLazL130R) cannot rescue courtship behavioral phenotypes. Our data suggest a 
specific function of NLaz as a mediator of pheromone signals, either at modulating 
their availability in the extracellular milieu or its reception by the sensory neurons in 
charge. 
Also, the transcriptional changes monitored in our study clearly show that NLaz 
acts upstream of key pathways modulating the management of resources upon stress 
or aging. Many of the genes with NLaz-dependent responses to aging or PQ are in 
fact genes regulated by the IIS pathway, either as direct FOXO targets (Lip4, Gadd45, 
Sod2, Pepck, and sNPF) or downstream of the TOR pathway (Thor). This further 
supports our previous findings of a negative control of IIS activity by NLaz (16), and 
suggests additional consequences derived from NLaz function. Noticeably, only some 
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of these transcriptional rescues are dependent on the binding pocket modification of 
NLazL130R. 
 
Our results show that altering the binding pocket environment differentially affects a 
subset of NLaz functions. Aging and stress resistance regulation are part of an 
ancestral set of functions conserved in NLaz-related homologues (5, 57, 68, 69). 
Since these roles are affected overall by a single site mutation in the pocket that 
prevents binding of some potential ligands, the integrity of the inter-molecular 
interactions involving the conserved NLaz L130 residue is clearly required for these 
functions. Another important finding of our study is that a native binding pocket is not 
required to rescue some NLaz-dependent metabolic phenotypes and a significant 
proportion of transcriptional phenotypes downstream of NLaz action upon PQ or 
aging. These data challenge the view that the integrity of the ligand binding pocket is 
essential for all molecular mechanisms of action of NLaz. 
 
The new findings help us to refine our previous conclusions about modulation of 
lifespan through the control of metabolism under stress conditions by NLaz (16). We 
previously proposed that the lifespan expanding activity of NLaz was due to the 
systemic action of fat body-derived NLaz on peripheral target tissues, inhibiting IIS 
and therefore repressing growth (16). Also, we showed that a constitutive lack of 
NLaz function significantly increases the hunger-driven food intake behavior of the 
flies, and that they gain weight (particularly fat) with aging (18). Now we find that 
NLaz mutants have an aging-dependent increased expression of sNPF, a gene 
involved in food intake and body size (66). This result provides a possible explanation 
for the food intake and “age-related obesity” phenotypes, and highlights new actions 
of NLaz within the CNS. NLaz might exert a negative regulation of the expression of 
sNPF downstream of FOXO in the neuropeptidergic neurons, thus contributing, in 
addition to its systemic control, to the final metabolic-nutritional status and lifespan of 
the flies. 
We also find that under oxidative stress NLaz modulates the expression of Ilp4 in a 
binding pocket-dependent manner. Ilp4 is one of the insulin-like peptides described to 
be part of the CNS specific pool, and it is known to contribute to reactivate 
neurogenesis during larval development (61), but not to organismal growth. 
Curiously, NLaz does not alter the expression of Ilp2, Ilp3 or Ilp5 (16), the systemic 
pool of insulin-like peptides in Drosophila that control organismal growth. 
 
In summary, our work, using NLaz as a model lipocalin and taking advantage of 
standardized Drosophila genetic tools, opens the way to identify residues in the 
binding pocket of lipocalins that are required for complex physiological roles tested in 
a living organism. These and future results studying other residues in the lipocalin 
hydrophobic pocket will allow us to experimentally address in vivo the more general 
question of whether ligand binding can account for the full panoply of Lipocalin 
actions in the organism. 
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FIGURE AND TABLE LEGENDS 
 
Figure 1. NLaz primary and tertiary structures and intrinsic fluorescence 
analysis of NLaz-ligand interactions. 
(A) NLazWT amino acid sequence structure. Residues selected to generate point 
mutant versions of NLaz are boxed in gray and highlighted (L130 in red, N165 in 
blue). The C-terminal fragment deleted in NLazΔ177-192 mutant is underlined. Some 
Asn residues are highlighted by rectangles; green for proved and purple for predicted 
glycosylation. 
(B) 3D-surface model of NLaz using hApoD crystal coordinates as a template. The 
left panel shows wild-type NLaz with the pocket indicated by a curved arrow and the 
L130 residue highlighted in yellow. The right panel shows a similar view of the 
model for NLazL130R protein, with the Arg basic group marked in red and indicated by 
a white arrow. 
(C-H) Changes in intrinsic fluorescence of NLazWT and NLazL130R with different 
hydrophobic compounds are shown. NLazWT fluorescence is quenched by retinoic 
acid (C), and enhanced by ergosterol (D) and the Drosophila pheromone 7(z)-
tricosene (E). NLazL130R fluorescence is quenched by retinoic acid (F), but no 
interaction was found for NLazL130R with ergosterol (G) or 7(z)-tricosene (H). 
 
Figure 2. NLazL130R shows lower survival promoting activity than NLazWT both 
in cultured S2 cells and in adult flies upon aging or exposure to stress. 
(A) Drosophila S2 cell viability was measured by trypan blue dye exclusion. S2 cells 
improve their survival upon exposure to hydrogen peroxide (20 mM H202) when 50 
nM of exogenous pure NLazWT or NLazL130R proteins are added to the culture 
medium. Trypsin Inhibitor (TI, 50 nM), added as a control unrelated protein, does not 
influence cell survival. Two-way ANOVA (p<0.001) followed by Holm-Sidak 
multiple comparison post-hoc test indicates that the recovery of viability obtained 
with NLazWT is significantly larger than that obtained with NLazL130R. **= p<0.001. 
(B) PQ resistance of 3 day-old flies with ubiquitous over-expression of NLazWT or 
NLazL130R in wild type background is not significantly different from that of control 
flies. However, over-expression of NLazWT confers more resistance to PQ than over-
expression of NLazL130R. 
(C) Upon aging (30 day-old flies) resistance to PQ is increased by ubiquitous over-
expression of NLazWT. However, old flies over-expressing NLazL130R are more 
sensitive to PQ than control flies.  
(D) Three day-old flies ubiquitously over-expressing NLazWT show a more extended 
survival to PQ treatment than NLazNW5 homozygous flies. However, NLazL130R 
expression is only able to exert a partial rescue. 
(E) In the absence of added stress, the reduced longevity of null NLaz fly mutants is 
rescued by the ubiquitous over-expression of NLazWT (evident in terms of maximal 
survival; see Table 2). However, over-expression of NLazL130R fails to rescue NLaz 
loss-of-function longevity, showing a lifespan shorter than that of NLazNW5 
homozygous flies.  
(F) NLazWT ubiquitous over-expression rescues the phenotype of sensitivity to 
starvation-desiccation stress in three day-old NLazNW5 flies, while NLazL130R 
expression is only able to exert a partial rescue. 
To compare survival distributions, log-rank tests were performed (p-values shown in 
each panel) followed by Holm-Sidak multiple comparison post-hoc tests. Differences 
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between NLazNW5 and NLazWT in D was further assessed by the Cox’s F-test (p = 
0.002) and the Cox-Mantel test (p = 0.004). 
 
Figure 3. Aging-related markers accumulation and fly reproductive behavior are 
dependent on NLaz ligand-binding pocket integrity. 
(A) Advanced glycation end products (AGEs), which normally accumulate upon 
aging, are increased at 3 and 30 days in NLaz null mutants, reflecting an accelerated 
aging process. NLazWT over-expression rescues this phenotype, whereas NLazL130R 
over-expression is not able to reduce AGEs accumulation. We use heterozygous 
+/NLazNW5 flies with a single copy of wild type NLaz in its native locus as a control. 
Two-way ANOVA followed by Holm-Sidak multiple comparison post-hoc test. ** =  
p < 0.001; * = p < 0.005. (NLazNW5, n=29; NLazWT, n=29; NLazL130R, n=25). 
(B) Courtship behavior index is reduced in NLazNW5 flies. NLazWT ubiquitous over-
expression rescues this phenotype completely.  Although the null hypothesis cannot 
be rejected (the test assumes similarly shaped distributions among groups), NLazL130R 
expression results in a courtship index whose distribution is more similar in shape to 
the null mutant than to the wild type control. Kruskal-Wallis one-way ANOVA on 
ranks followed by Dunn’s multiple comparison post-hoc test. * = p < 0.005 (n=25-30 
couples/genotype). 
 
Figure 4. Effects of NLazWT and NLazL130R in the fly metabolic homeostasis. 
Fly metabolic measurements were performed at basal state and after 8h of starvation-
desiccation. Depletion of metabolite stores is represented as % of control levels.  
(A) Triglyceride depletion by starvation is bigger in NLazNW5 flies compared to 
control flies. Neither NLazWT nor NLazL130R, ubiquitously over-expressed in the 
NLazNW5 genetic background, rescue the triglyceride reduction. 
 (B) Glucose levels after starvation also depends on NLaz expression, but alteration of 
the NLaz binding pocket structure does not significantly change the responses. 
NLazNW5 starved flies present lower levels of glucose compared to control flies, and 
both NLazWT and NLazL130R over-expressions partially rescue this phenotype. 
(C) Glycogen storage depletion depends on NLaz expression, but not on NLaz 
binding pocket structure. Both NLazWT and NLazL130R maintain equally significant 
higher levels of glycogen stores after starvation. 
(A-B) One-way ANOVA on ranks followed by Tukey multiple comparison post-hoc 
tests. (C) One-way ANOVA followed by Tukey multiple comparison post-hoc tests. 
**= p<0.001; *= p<0.05. 
 
Figure 5. Transcriptional profile analysis shows binding pocket-dependent and 
independent NLaz modulation of stress and age-responsive pathways.  
(A) Subset of genes where the response to PQ shows dependence on NLaz genotype. 
Only genes with expression changes≥2 (p < 0.05) and showing a rescuing effect by 
either of the NLaz transgenes (fold regulation similar to the WT control) are shown. 
Boxes indicate genes in which the rescue is dependent on the binding pocket mutation 
(differential rescue). Genes with large expression changes are shown in separate 
graphs for scaling purposes. 
(B) Percent distribution of genes with transcriptional changes upon PQ or aging 
classified according to the ability of NLaz transgenes to revert the changes observed 
in the NLazNW5 null mutant genotype. 
(C) Subset of genes whose response to aging is NLaz-dependent. Inclusion criteria as 
in A. Boxes indicate genes with binding pocket-dependent rescue, with dashed boxed 
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showing cases with partial dependence. Genes with large expression changes are 
shown in separate graphs for scaling purposes. 
Student’s t-test was performed on the quadruplicate 2-ΔCt values for each gene in each 
genotype. Fold regulation by either PQ or aging is shown as 2-ΔΔCt when the 
experimental condition produced an increase in expression, and as -1/2-ΔΔCt when the 
condition produced down-regulation of the gene. 
 
Table 1. Primer sequences used for PCR. 
 
Table 2. Effects of ubiquitous expression of different versions of NLaz on fly 
survival and behavior. 
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Table 1. Primer sequences. 
 
Application Primer Sequence 
Mutagenesis L130R 
5'-gccaatttcaaaattgtttggatccgcactcgtcagcgtgaaccttcagc-3'
5'-gctgaaggttcacgctgacgagtgcggatccaaacaattttgaaattggc-3'
NLazWT and NLazL130R qRT-
PCR 
5'-cgagtacgcagcctatccat-3’ 
5'-ccaggtagttggccttcgt-3’ 
5'-ggttcacgctgacgagtgcg-3’ 
DrpL18 qRT-PCR 
5'-agaaccgagcccaaatcc-3’ 
5'-cgaccacgatggtagactcc-3’ 
From pBS-II to pRmHa-3 
5’-caagaattctcagtggatagcgac-3’ 
5’-caagcggccgcggagccgcgcggcaccagtgccttttcaatggcatttgc-3’ 
NLaz-Δ177-192 
from pBSII-KS to pUASt-attB 
5’-cgaattctcagtggatagcgac-3’ 
5’-cgaattctcaaccatccaaccg-3’ 
Sequence pBSII-KS Universal Primer Set (CIC) 
Sequence pUASt-attB 
5’-gcagtaaagtgcaagttaaagtga-3’ 
5’tgtccaattatgtcacaccac-3’ 
Sequence pRmHa-3 5’ccagagcatctggccaatgtgc-3’ 
Wolbachia rRNA-16S 
5′-gaagataatgacggtactcac-3′ 
5′-gtcagatttgaaccagataga-3′ 
Table 2.Effects of ubiquitous expression of different versions of NLaz on fly survival. 
 
Background ♂ da>UAS transgene N Experiment 
ANOVA 
p-value 
Log Rank Test  t-Test 
p-value 
%Change 
Median 
Survival 
p-value 
%Change 
Maximal 
Survival 
WT (w1118) 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazΔ177-192 
 
67 / 72 
 
67 / 68 
 
67 / 70 
 
67 / 71 
Paraquat  
(3 d) 0.02 
0.005 
 
0.533 
 
0.080 
 
0.079 
 
38.74 
 
23.14 
 
-13.92 
 
21.49 
 
0.318 
 
0.073 
 
0.017 
 
0.073 
-6.50 
 
-6.50 
 
-6.50 
 
-6.50 
WT (w1118) 
 
NLazWT 
 
NLazL130R 
 
67 / 71 
 
67 / 74 
Paraquat  
(30 d) <0.001 
0.002 
 
0.019 
13.56 
 
-13.46 
<0.001 
 
0.026 
40.16 
 
-8.90 
NLazNW5 
(NLaz-KO)
 
NLazWT 
 
NLazL130R 
 
147 / 126 
 
147 / 76 
 
Longevity <0.001 
0.005 
 
<0.001 
1.75 
 
-15.79 
<0.001 
 
<0.001 
17.65 
 
-19.72 
NLazNW5 
(NLaz-KO)
 
 
NLazN165S 
 
NLazWT 
 
NLazL130R 
 
NLazΔ177-192 
 
153 / 106 
 
153 / 128 
 
153 / 93 
 
153 / 120 
Paraquat 
(3 d) <0.001 
<0.001 
 
<0.001 
 
<0.001 
 
<0.001 
181.51 
 
90.4 
 
36.09 
 
47.20 
<0.001 
 
<0.001 
 
<0.001 
 
<0.001 
46.04 
 
46.04 
 
23.68 
 
46.04 
NLazNW5 
(NLaz-KO)
 
 
NLazWT 
 
NLazL130R 
 
119 / 150 
 
119 / 76 
Desiccation <0.001 
<0.001 
 
0.002 
22.26 
 
22.26 
<0.001 
 
0.964 
21.74 
 
0.00 
 
The first number in the third column accounts for N in the background sample, and the second 
number is N for the UAS transgene sample. 
Figure S1
Supplementary Figure 1. Protein purifications and fly lines characterization tests.
(A) Purification of NLazWT and NLazL130R from S2 cells. Size-exclusion chromatography elution profiles of enriched
extracts obtained after metal affinity chromatography of culture media from stably transfected S2 cells.
(B) SDS-PAGE analysis of NLazWT purified from S2 cells (left panel). The redox-state of the protein affects slightly
its electrophoretic mobility, while a large shift is observed after deglycosylation. No differences in electrophoretic
mobility are detected between NLazWT and NLazL130R purified from S2 cells (right panel).
(C) Fly lines used in this study are free of Wolbachia infection. PCR of genomic DNA extracts from all lines
employed. Primers against the rRNA-16S gene of Wolbachia endosymbiont were used (Table 1). DNA from
Dirofilaria immitis worms infected with Wolbachia was used as a positive control.
(D) NLaz transcription levels in transgenic flies expressing NLazWT, NLazL130R, NLazN165S and NLaz177-199. We used
a pair of primers able to amplify both forms, and a mutant-specific primer that does not amplify the WT allele (Table
1). Expression NLaz levels are comparable in all over-expressors. The mRNA levels of the NLazL130R mutant version
are similar to those of the WT transcript in the transgenic flies where we observe differences in NLaz phenotypes.
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Supplementary Figure 2. Deletion of the C-terminal portion (177-199) of NLaz and the NLazN165S variant alter
stress resistance.
(A) Model of NLazN165S protein structure compared to NLazWT. Backbone and surface models are superimposed. A
lateral view is shown. The binding pocket is pointed by an arrow and is outlined by a dashed line. N165 or S165
residues are labeled in green.
(B) Over-expression of NLazN165S in a wild-type genetic background is able to increase fly resistance against PQ when
compared to control flies at 3 days of age.
(C) Resistance to paraquat of young flies expressing NLazN165S in NLazNW5 null background is higher than that of flies
expressing NLazWT.
(D) Ubiquitous over-expression of both NLazWT and NLazΔ177-199 in wild-type background does not increase
significantly the resistance to PQ in young flies.
(E) NLazΔ177-199 expression rescues the PQ phenotype when expressed in NLazNW5 null mutant background.
Log-rank tests followed by Holm-Sidak multiple comparison post-hoc tests were used in B-E.
Supplementary Data File 1 .  Transcriptional profile data. Genes selected for expression studies and gene expression in basal conditions.
Transcriptional profile data. Tables S1 and S2.
Table S1. Genes selected for expression studies.
Gene Symbol Refseq # RT2 Cat.No.
Act5C NM_001014725 PPD00467
Akt1 NM_169705 PPD09200
bsk NM_164900 PPD11004
Cat NM_080483 PPD07567
CG12374 NM_136975 PPD04510
CG8147 NM_001038951 PPD08516
Ddc NM_078876 PPD03531
desat1 NM_144474 PPD11642
Dpt NM_057460 PPD05159
Drs NM_079177 PPD06186
foxo NM_142073 PPD08986
Gadd45 NM_136420 PPD03876
Gapdh1 NM_001038847 PPD03944
GLaz NM_079003 PPD04541
Gr66a NM_079247 PPD06616
GstE1 NM_137479 PPD05094
GstS1 NM_079043 PPD66725
Hr96 NM_079769 PPD10079
Hsp68 NM_001031945 PPD13069
Ilp4 NM_140104 PPD06800
InR NM_079712 PPD09691
Jafrac1 NM_058162 PPD11559
Karl NM_132520 PPD00966
Lip4 NM_135574 PPD02897
Lsd-1 NM_142926 PPD09917
Lsp2 NM_080077 PPD11062
Mgstl NM_079957 PPD10883
mio NM_134812 PPD02026
Nplp3 NM_144453 PPD11605
Pepck NM_079060 PPD05115
Prx2540-2 NM_078959 PPD04249
puc NM_079549 PPD08362
RpL18 NM_139834 PPD06501
RpL32 NM_079843 PPD10569
S6k NM_079217 PPD06382
Sir2 NM_058003 PPD03110
sNPF NM_078881 PPD03613
Sod2 NM_057577 PPD04905
Spt-I NM_136998 PPD04542
synaptogyrin NM_137064 PPD04615
Thor NM_057947 PPD02171
Tk NM_141884 PPD08785
to NM_079773 PPD10117
whd NM_078961 PPD04258
Controls
DGDC SA_00146 PPD66893
RTC SA_00104 PPX63340
PPC SA_00103 PPX63339
Gene Symbol Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value
Act5C 1.001 0.96843 1.289 0.08226 1.281 0.06374
Akt1 -1.172 0.03538 -1.298 0.00568 -1.447 0.00460
bsk -1.011 0.92925 -1.069 0.71340 -1.032 0.69246
Cat -1.132 0.37087 -1.057 0.56660 1.145 0.45657
CG1237 -1.038 0.45605 -1.534 0.00009 -2.228 0.00002
CG8147 -1.483 0.00259 -10.367 0.00000 -3.809 0.00001
Ddc 1.008 0.93340 1.047 0.68979 1.168 0.14218
desat1 -1.051 0.46832 -1.243 0.04395 -1.078 0.27147
Dpt 4.410 0.00002 63.570 0.00000 13.513 0.00000
Drs -1.113 0.65387 4.599 0.00004 1.456 0.00750
foxo -1.345 0.00976 -1.313 0.00438 -1.450 0.00158
Gadd45 -1.307 0.12868 -1.220 0.13537 -1.060 0.72584
Gapdh1 -1.352 0.19108 -1.425 0.05864 -1.303 0.07286
GLaz 1.009 0.87518 -1.082 0.10049 -1.263 0.00782
Gr66a -1.340 0.33279 -1.177 0.49413 1.247 0.47097
GstE1 -1.191 0.68953 1.382 0.20157 1.241 0.29282
GstS1 -1.301 0.00370 -1.962 0.00010 -1.838 0.00038
Hr96 -1.076 0.48599 -1.295 0.02979 -1.015 0.83008
Hsp68 -1.268 0.00516 -1.203 0.02425 -1.371 0.00223
InR -1.586 0.00060 -1.929 0.00016 -1.383 0.01687
Jafrac 1.101 0.19687 1.079 0.14682 1.022 0.76704
Karl -2.434 0.00022 2.674 0.00000 1.026 0.77165
Lip4 1.311 0.02100 -1.253 0.02485 -1.203 0.06966
llp4 -4.167 0.02306 -4.076 0.03266 -3.060 0.04019
Lsd-1 -1.271 0.00975 -1.992 0.00001 -1.618 0.00012
Lsp2 1.088 0.56817 2.084 0.00010 -1.009 0.88738
Mgstl -1.023 0.89408 1.203 0.17277 1.254 0.09054
mio -1.895 0.03709 -2.085 0.06450 -2.276 0.04994
Nplp3 -1.825 0.00030 -2.665 0.00002 -2.892 0.00003
Pepck -1.624 0.00040 1.115 0.08810 1.276 0.00589
Prx254 1.049 0.54468 -1.223 0.03380 1.150 0.09191
puc -1.142 0.03390 -1.366 0.02986 -1.132 0.37226
RpL18 1.160 0.55173 1.392 0.14750 1.757 0.00801
RpL32 1.000 1.00000 1.000 1.00000 1.000 1.00000
S6k -1.372 0.04942 -1.623 0.00530 -1.499 0.02345
Sir2 1.050 0.60638 -1.093 0.17760 -1.019 0.72289
sNPF -1.154 0.37812 -1.115 0.33652 -1.154 0.22055
Sod2 -1.129 0.37138 -1.099 0.33513 -1.122 0.35336
Spt-l 1.262 0.02655 1.009 0.90201 -1.075 0.41873
synapt -1.226 0.00053 -1.169 0.00209 -1.163 0.20411
Thor -1.277 0.00136 -1.354 0.00163 1.154 0.02945
Tk -1.003 0.87159 -1.880 0.01431 -1.525 0.07503
to -1.221 0.04269 -1.030 0.54535 -1.349 0.00015
whd -1.473 0.00002 -1.579 0.00004 -1.353 0.03662
Lipid metabolism
Technical control
Technical control
Technical control
Lipid metabolism
Neural activity/ Lifespan-Aging modulation
Metabolism control  (IIS - TOR pathways)
Neuropeptide hormones / Stress response
Lipid metabolism / Lifespan-Aging modulation
Housekeeping
Metabolism control pathway
Lifespan-Aging modulation /  Metabolism control
Neuropeptide hormones / Food intake regulation / Stress response
Oxidative stress response
Neural activity/ Lifespan-Aging modulation
Carbohydrate metabolism (Foxo target)
Oxidative stress response
Stress response pathway  (JNK pathway)
Housekeeping
Metabolism control  (Foxo target)
Lipid metabolism
Lifespan-Aging modulation
Oxidative stress response
Lipid metabolism
Oxidative stress response (JNK pathway)
Metabolism control / Neurogenesis control (IIS pathway)
Metabolism control (IIS pathway)
Oxidative stress response (Foxo target)
Lipocalin family / Immune response
Lipocalin family / Oxidative stress response
Chemoreception in pheromone sensing neurons
Oxidative stress response
Oxidative stress response
Lipid homeostasis
Reverse Transcription Control
Positive PCR Control
Functional category
Housekeeping
Metabolism control  (IIS pathway)
Stress response pathway (JNK pathway)
Oxidative stress response (Foxo target)
Age/Oxiative stress specific response (vs. starvation/infection)
Age/Oxiative stress specific response (vs. starvation/infection)
Neurotransmitter/Hormonal systems
Lipid / Hormonal systems
Immune response
Immune response
Metabolism control (IIS and Sir2 pathways)
Oxidative stress response-DNA repair (Foxo target)
Housekeeping
Tachykinin
Takeout
Withered
Fly Genomic DNA Contamination
Short neuropeptide F precursor
Superoxide dismutase 2 (Mn-SOD)
Serine palmitoyltransferase subunit I
Synaptogyrin
Thor / 4E-BP (eIF4E binding protein)
Puckered (JNK-specific phosphatase)
Ribosomal protein L18
Ribosomal protein L32
RPS6-p70-protein kinase
NAD-dependent histone deacetylase Sir2
Gustatory receptor 66a
Glutathione S transferase E1
Microsomal glutathione S-transferase-like
Missing oocyte
Neuropeptide-like precursor 3
Phosphoenolpyruvate carboxykinase
Peroxiredoxin 2540-2
Thioredoxin peroxidase 1
Karl
Lipase 4
Lipid storage droplet-1
Larval serum protein 2
-/- ; da>+ -/- ; da>Nlaz-WT -/- ; da>Nlaz-L130R
Official Name / Mamalian orthologue
Actin 5C
serine/threonine-protein kinase
Basket / JNK
Catalase
Carboxypeptidase-like (Zn) CG12374
Alkaline phosphatase-like CG8147
Dopa decarboxylase
Desaturase 1
Diptericin
Drosomycin
Forkhead box, sub-group O
Table S2. Gene expression comparisons in basal conditions. Expression in flies of each genotype at 3 days of age was compared with the 
w1118 ; NLaz NW5/+ ; da:Gal4/+ control. p values are calculated based on a Student’s t-test of the replicate 2-∆Ct values for each gene in 
the control group and treatment groups. p values less than 0.05 are indicated in red. Up-regulations are shown in red and down-regulations in 
blue.
Glutathione S transferase S1
Hormone receptor-like in 96
Heat shock gene 68
Insulin-like peptide 4
Insulin-like receptor
Growth arrest and DNA damage-inducible
Glyceraldehyde 3 phosphate dehydrogenase 1
Glial Lazarillo
Supplementary Data File 2. Transcriptional profile data. Gene expression changes triggered by Paraquat treatment and aging.
Transcriptional profile data. Tables S3 and S4.
Gene Symbol Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value
Act5C 1.080 0.64586 1.084 0.67628 -1.137 0.14188 1.567 0.00000
Akt1 1.017 0.82186 1.450 0.00007 1.380 0.00123 1.571 0.00027
bsk -1.349 0.22559 1.046 0.86969 1.143 0.44734 1.279 0.03281
Cat -1.039 0.76239 1.556 0.00022 1.183 0.00295 1.524 0.01534
CG1237 -9.970 0.00000 -13.674 0.00000 -7.387 0.00000 -5.051 0.00000
CG8147 -27.606 0.00000 -44.839 0.00000 -5.805 0.00000 -13.511 0.00000
Ddc -1.516 0.01410 -1.337 0.02769 -1.354 0.00493 1.056 0.32784
desat1 -2.420 0.00010 -2.027 0.00001 -1.600 0.00248 -1.396 0.00021
Dpt 2.255 0.00004 1.991 0.00004 -20.740 0.00000 -2.257 0.00008
Drs 1.812 0.02333 2.340 0.00036 -2.473 0.00026 1.512 0.00036
foxo -1.774 0.00019 -1.251 0.01420 -1.442 0.00010 -1.072 0.16082
Gadd45 3.419 0.00037 7.415 0.00000 2.620 0.00000 4.614 0.00001
Gapdh1 -3.602 0.00342 -1.567 0.07232 -2.174 0.00263 -1.045 0.44976
GLaz -2.141 0.00002 -2.221 0.00000 -1.667 0.00000 -1.181 0.04135
Gr66a -1.025 0.88273 2.954 0.00068 1.821 0.00593 1.535 0.01218
GstE1 10.947 0.00440 16.078 0.00007 6.604 0.00080 16.503 0.00000
GstS1 -1.759 0.00054 -1.230 0.00161 1.028 0.74450 1.217 0.10148
Hr96 -1.127 0.16779 -3.406 0.37900 1.063 0.54653 1.172 0.01844
Hsp68 1.399 0.00282 5.755 0.00000 2.288 0.00001 1.732 0.00000
InR 1.897 0.00025 4.467 0.00000 3.141 0.00091 2.096 0.00084
Jafrac 1.425 0.00138 1.278 0.00169 1.183 0.00266 2.353 0.00001
Karl -1.894 0.00325 1.347 0.02570 -1.951 0.00005 1.719 0.00298
Lip4 2.035 0.00002 1.002 0.96271 2.575 0.00000 3.274 0.00000
llp4 -3.488 0.03697 2.117 0.18010 -1.140 0.58492 1.010 0.93531
Lsd-1 -1.962 0.00002 -2.408 0.00005 -1.036 0.27274 1.496 0.00007
Lsp2 -2.490 0.00216 1.346 0.00192 -3.066 0.00000 1.225 0.06080
Mgstl -1.434 0.05709 -1.209 0.15701 -1.551 0.00013 1.107 0.01213
mio 1.025 0.96199 2.531 0.00023 -1.079 0.79606 2.002 0.16243
Nplp3 -3.814 0.00001 -4.428 0.00002 -6.671 0.00000 -1.409 0.02443
Pepck 2.379 0.00021 4.731 0.00000 3.471 0.00002 2.212 0.00000
Prx254 2.950 0.00000 2.509 0.00001 1.732 0.00012 1.245 0.00331
puc 1.371 0.00356 2.508 0.00001 1.271 0.23545 1.576 0.09594
RpL18 1.146 0.58380 1.026 0.91643 1.106 0.51049 1.432 0.00059
RpL32 1.000 1.00000 1.000 1.00000 1.000 1.00000 1.000 1.00000
S6k -1.581 0.01124 -1.090 0.48048 -1.149 0.32823 1.051 0.74253
Sir2 -1.113 0.27683 1.311 0.01832 1.203 0.01185 1.151 0.00934
sNPF -1.148 0.22731 1.291 0.09971 1.122 0.18456 1.235 0.00856
Sod2 -1.663 0.00942 -1.314 0.02937 -1.523 0.00000 1.064 0.46572
Spt-l -1.404 0.00161 -1.628 0.00102 -1.245 0.00952 -1.080 0.36353
synapt -1.571 0.00005 -1.012 0.81790 -1.014 0.86483 1.034 0.85412
Thor 2.277 0.00007 4.880 0.00000 2.923 0.00001 2.299 0.00000
Tk -1.561 0.04728 -1.402 0.00588 1.484 0.01579 1.383 0.06986
to -1.183 0.08093 1.092 0.36494 1.318 0.00477 1.476 0.00005
whd -1.184 0.00271 1.270 0.00164 1.200 0.00603 1.115 0.53095
Gene Symbol Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value Fold Regulation p-value
Act5C -1.542 0.06321 1.197 0.29363 -1.401 0.02413 2.156 0.00001
Akt1 -1.672 0.00040 1.625 0.00192 -1.183 0.02144 1.806 0.00007
bsk -1.837 0.02556 1.376 0.07002 -1.777 0.06654 1.875 0.00001
Cat -1.140 0.59566 2.002 0.00058 1.043 0.64200 1.371 0.04269
CG1237 -4.017 0.00000 -13.712 0.00000 -3.657 0.00000 -7.343 0.00000
CG8147 -8.803 0.00000 -22.907 0.00000 2.798 0.00001 -1.316 0.00001
Ddc -1.995 0.00307 1.068 0.58010 -1.713 0.00064 1.256 0.02046
desat1 -1.288 0.02715 -1.771 0.00094 1.444 0.00859 -1.115 0.05137
Dpt 1.171 0.23333 -1.130 0.22003 -3.122 0.00000 42.877 0.00000
Drs -1.228 0.38725 2.511 0.00032 -4.091 0.00006 14.817 0.00000
foxo -1.542 0.00102 -1.159 0.33855 -1.211 0.02149 1.387 0.00010
Gadd45 -2.492 0.00519 13.009 0.00000 -1.167 0.08599 2.936 0.00001
Gapdh1 -9.964 0.00018 1.433 0.08215 -5.559 0.00020 -3.726 0.00000
GLaz -1.743 0.00095 -1.909 0.00002 -1.544 0.00000 1.054 0.37975
Gr66a -1.385 0.36476 5.332 0.00015 1.324 0.20643 2.294 0.00013
GstE1 -1.217 0.80575 26.472 0.00006 1.313 0.14101 4.203 0.00000
GstS1 -4.133 0.00002 -1.053 0.49674 -2.662 0.00364 -1.360 0.01648
Hr96 -1.678 0.00351 1.214 0.15648 -1.093 0.21807 1.335 0.00199
Hsp68 -2.046 0.00005 6.524 0.00002 -1.970 0.00004 2.660 0.00000
InR -2.084 0.00230 4.690 0.00011 1.042 0.59538 2.500 0.00004
Jafrac -1.330 0.01034 1.632 0.00333 -1.189 0.00028 1.491 0.00054
Karl -4.532 0.00007 1.622 0.01491 -1.255 0.00156 1.960 0.00002
Lip4 -1.181 0.12714 1.067 0.51384 1.045 0.10813 1.686 0.00004
llp4 -4.712 0.02160 3.039 0.02089 -3.311 0.29345 1.306 0.46516
Lsd-1 -1.848 0.00003 -1.924 0.00016 1.934 0.00087 1.004 0.94163
Lsp2 1.167 0.32893 1.717 0.00036 3.499 0.00000 2.975 0.00001
Mgstl -1.816 0.01465 -1.060 0.55326 -1.362 0.01045 -1.145 0.01262
mio -2.228 0.02669 2.815 0.00309 -2.186 0.52800 2.559 0.00214
Nplp3 -28.416 0.00000 -1.792 0.00253 -10.340 0.00000 -3.613 0.00027
Pepck 1.936 0.00003 5.351 0.00002 2.970 0.00011 1.335 0.00043
Prx254 -2.002 0.00019 3.876 0.00011 -1.912 0.00001 -1.184 0.00754
puc -1.840 0.00880 3.589 0.00002 -1.854 0.65336 3.579 0.00000
RpL18 1.142 0.55893 1.465 0.12492 1.546 0.01499 1.307 0.01551
RpL32 1.000 1.00000 1.000 1.00000 1.000 1.00000 1.000 1.00000
S6k -1.825 0.00455 1.061 0.68089 -1.090 0.17141 1.473 0.00468
Sir2 -1.373 0.00288 1.927 0.00048 -1.024 0.70739 1.790 0.00002
sNPF -1.473 0.08927 1.492 0.01589 -1.206 0.10719 2.058 0.00002
Sod2 -3.013 0.00072 1.194 0.13122 -1.899 0.00000 -1.563 0.00231
Spt-l -1.284 0.03626 -1.303 0.05097 -1.448 0.00049 1.355 0.00208
synapt -3.063 0.00000 1.473 0.00262 -2.000 0.00001 1.018 0.96504
Thor -2.229 0.00001 6.340 0.00002 1.088 0.14582 1.326 0.00044
Tk -2.567 0.00561 -1.181 0.06543 -1.490 0.04258 1.233 0.24832
to -1.403 0.00485 1.492 0.00536 1.641 0.00029 2.100 0.00000
whd -1.503 0.00081 1.548 0.00278 1.068 0.57877 1.382 0.02675
Table S3. Gene expression comparisons of 3 days flies treated for 17 h with PQ with control flies of each genotype. p values are calculated 
based on a Student’s t-test of the replicate 2-∆Ct values for each gene in the control group and treatment groups. p  values less than 0.05 are 
indicated in red. Up-regulations are shown in red and down-regulations in blue.
Table S4. Gene expression comparisons of 3 vs. 30 day-old flies of each genotype. p values are calculated based on a Student’s t-test of the 
replicate 2-∆Ct values for each gene in the control group and treatment groups. p  values less than 0.05 are indicated in red. Up-regulations are 
shown in red and down-regulations in blue.
+/- ; da>+ (30 d vs. 3 d) -/- ; da>+ (30 d vs. 3 d) -/- ; da>Nlaz-WT (30 d vs. 3 d) -/- ; da>Nlaz-L130R (30 d vs. 3 d)
+/- ; da>+ (PQ vs. Control) -/- ; da>+ (PQ vs. Control) -/- ; da>Nlaz-WT (PQ vs. Control) -/- ; da>Nlaz-L130R (PQ vs. Control)
